Cargando…
S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA
Autores principales: | Derrien, Jennifer, Gastineau, Sarah, Frigout, Antoine, Giordano, Nils, Cherkaoui, Mia, Gaborit, Victor, Douillard, Elise, Devic, Magali, Magrangeas, Florence, Moreau, Philippe, Minvielle, Stéphane, Touzeau, Cyrille, Letouzé, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428458/ http://dx.doi.org/10.1097/01.HS9.0000967656.64179.85 |
Ejemplares similares
-
Exploring the impact of dexamethasone on gene regulation in myeloma cells
por: Bessonneau-Gaborit, Victor, et al.
Publicado: (2023) -
The DNA methylation landscape of multiple myeloma shows extensive inter- and intrapatient heterogeneity that fuels transcriptomic variability
por: Derrien, Jennifer, et al.
Publicado: (2021) -
S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)
por: Touzeau, Cyrille, et al.
Publicado: (2023) -
S196: ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM MAGNETISMM-3
por: Mohty, Mohamad, et al.
Publicado: (2023) -
Constraints on signaling network logic reveal functional subgraphs on Multiple Myeloma OMIC data
por: Miannay, Bertrand, et al.
Publicado: (2018)